Loading company…
Seoul biotech focused on early diagnosis and treatment of protein misfolding diseases such as Alzheimer's.
Established in 2002 and based in Seoul, South Korea, PeopleBio works on early diagnosis and treatment of protein misfolding diseases. Its main product is the OAß Test Automated System, which measures beta-amyloid oligomerization in people suspected of having Alzheimer's disease. The company is also developing multimer detection systems for Alzheimer's, diabetes and Parkinson's. It is listed in South Korea, and in June 2021 iMarket Korea, NAU IB Capital and BNH Investment invested KRW 12.999 billion in a PIPE deal. Stage: Series B.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in